Autor/in Denzer, Ulrike Distelrath, A 1 Ebert, M P 1 Geissler, M 1 Kanzler, S 1 Kolligs, F T 1 Maderer, A 1 Moehler, M 1 Schimanski, C 1 Schütz, M Trojan, J 1 alle zeigenListe einklappen
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme Moehler, M Maderer, A Schimanski, C Kanzler, S Denzer, Ulrike Kolligs, F T Ebert, M P 2014 - Forschungsinformationssystem des UKE
